Target intelligence / Profile preview

Chorionic gonadotropin subunit beta 7 (CGB7)

Target
CGB7
Molecular classification
Other (subunit of glycoprotein hormone), Hormone subunit
01

Overview

Chorionic gonadotropin subunit beta 7 (CGB7) is a protein encoded by the CGB7 gene, one of several beta subunit family members that form human chorionic gonadotropin (hCG)[1][3]. hCG is a heterodimeric glycoprotein hormone consisting of a common alpha subunit (shared with other glycoprotein hormones) and a unique beta subunit, the latter conferring biological specificity[1][5]. Beta-hCG is crucial for the recognition and maintenance of early pregnancy, stimulating the ovaries to produce steroids needed to sustain gestation[1][3][5]. CGB7, together with other beta subunit genes (CGB3, CGB5, CGB8), is expressed primarily in placental trophoblastic cells, but also displays distinct tissue expression likely due to differences in regulatory sequences such as p53-responsive promoters[2]. Functionally, CGB7 forms part of the hCG hormone that acts through the LHCGR receptor to maintain the corpus luteum and support progesterone synthesis[5]. Levels of the beta-hCG subunit serve as biomarkers in pregnancy and certain malignancies such as choriocarcinoma and germ cell tumors[5]. CGB7 itself is not a therapeutic target per se, but pharmaceuticals utilize the hCG heterodimer containing the CGB7 (or homologous) subunits for reproductive medicine indications[5].

Other names
Choriogonadotropin subunit beta 7CG-beta-aCGB6chorionic gonadotropin beta 7 subunitchorionic gonadotropin beta subunit 7chorionic gonadotropin, beta polypeptide 7CGB7
02

Mechanism of action

Agonist of luteinizing hormone/choriogonadotropin receptor (LHCGR) when part of the hCG heterodimer, leading to stimulation of corpus luteum, progesterone production, maintaining pregnancy[5]

03

Biological functions

Hormone activityEssential for pregnancy maintenanceStimulates ovarian steroidogenesisSignal transduction (via hCG heterodimer interaction with the luteinizing hormone/choriogonadotropin receptor)
04

Disease associations

Cancer (e.g., choriocarcinoma)Ectopic pregnancyGestational trophoblastic disease
05

Safety considerations

Off-target effects if used diagnostically or therapeutically outside strict indicationsPotential for paraneoplastic syndromes due to ectopic production in cancer[5]
06

Interacting drugs

Human chorionic gonadotropin (as pharmaceutical preparations; not direct drugs against CGB7 but targeting hCG, which contains this subunit)

5 more in the full profile.

07

Biomarkers

Beta-hCG (used to monitor pregnancy, diagnose germ cell and trophoblastic tumors, ectopic pregnancy, and gestational trophoblastic disease)[5]

Beyond the preview

Go deeper on Chorionic gonadotropin subunit beta 7 (CGB7).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chorionic gonadotropin subunit beta 7 (CGB7).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call